Journal article
A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management
M Grossmann, AM Matsumoto
Journal of Clinical Endocrinology and Metabolism | ENDOCRINE SOC | Published : 2017
DOI: 10.1210/jc.2016-3580
Abstract
Context: Middle-aged and older men (50 years), especially those who are obese and suffer from comorbidities, not uncommonly present with clinical features consistent with androgen deficiency and modestly reduced testosterone levels. Commonly, such men do not demonstrate anatomical hypothalamic-pituitary-testicular axis pathology but have functional hypogonadism that is potentially reversible. Evidence Acquisition: Literature review from 1970 to October 2016. Evidence Synthesis: Although definitive randomized controlled trials are lacking, evidence suggests that in such men, lifestyle measures to achieve weight loss and optimization of comorbidities, including discontinuation of offending med..
View full abstractGrants
Funding Acknowledgements
Disclosure Summary: M.G. has received research funding from Bayer Schering, Novartis, Weight Watchers, and Eli Lilly, and speaker's honoraria from Besins Healthcare. A.M.M. has received research funding from AbbVie and GSK, consulting fees from AbbVie, Endo, Eli Lilly, Lipocine, USADA, and the Partnership for Clean Competition, and royalties from UpToDate.